登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《IJID，3月12日，Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-03-13

  • Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis

    JingYang, YaZheng, XiGou, KePu, ZhaofengChen, QinghongGuo, RuiJi, HaojiaWang, YupingWang, YongningZhou

    Show more

    https://doi.org/10.1016/j.ijid.2020.03.017

    Abstract

    Background

    An outbreak of Novel Coronavirus (COVID -19) in Wuhan, China, the epidemic is more widespread than initially estimated, with cases now confirmed in multiple countries.

    Aims

    The aim of the meta-analysis was to assess the prevalence of comorbidities in the COVID-19 infection patients and the risk of underlying diseases in severe patients compared to non-severe patients.

  • 原文来源：https://www.sciencedirect.com/science/article/pii/S1201971220301363
214浏览量
原文链接
相关报告

  • 《MedRxiv，3月16日，Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-17
    • Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection Vageesh Jain, Jin-Min Yuan doi: https://doi.org/10.1101/2020.03.15.20035360 Abstract Background/introduction COVID−19, a novel coronavirus outbreak starting in China, is now a rapidly developing public health emergency of international concern. The clinical spectrum of COVID−19 disease is varied, and identifying factors associated with severe disease has been described as an urgent research priority. It has been noted that elderly patients with pre-existing comorbidities are more vulnerable to more severe disease. However, the specific symptoms and comorbidities that most strongly predict disease severity are unclear. We performed a systematic review and meta-analysis to identify the symptoms and comorbidities predictive of COVID−19 severity. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    89浏览量
    原文链接

  • 《Respir Invest，6月28日，Trends in clinical features of novel coronavirus disease (COVID-19): A systematic review and meta-analysis of studies published from December 2019 to February 2020》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-06-29
    • Trends in clinical features of novel coronavirus disease (COVID-19): A systematic review and meta-analysis of studies published from December 2019 to February 2020 Author links open overlay panelToshieManabeaHiroyasuAkatsubKazuhikoKotaniaKoichiroKudocd Show more https://doi.org/10.1016/j.resinv.2020.05.005 Abstract Background Since novel coronavirus disease (COVID-19) emerged, various clinical features of COVID-19 have been reported. Methods We conducted a systematic review of published studies reporting the clinical features of COVID-19. Two investigators independently searched PubMed (December 2019–February 2020) for eligible articles. A meta-analysis was performed to measure the frequencies of clinical outcomes and symptoms of COVID-19. A stratified analysis was conducted according to the timeline of outbreak and exposure histories: Group I, most patients were exposed to the Hunan seafood wholesale market and lived in Wuhan, Hubei province; Group II, patients lived in Hubei province but were not directly exposed to the market; and Group III, patients lived outside Hubei.
    60浏览量
    原文链接